CDK4 and Alzheimer disease: More specifically, G1/S transition kinase Cdk4 activity is enhanced in vulnerable neurons in AD brains and inhibition of its activity by d/n or siRNA constructs protected neurons from death induced by NGF deprivation or Aβ exposure [15]–[17], [35].